Contact Us
Drug Search Results
More Filters [+]

Oxantel

Alternative Names: oxantel
Latest Update: 2024-12-06
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: nAChR Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Colombia | Dominican Republic | Ecuador | Hong Kong | Peru | Philippines | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Jennifer Keiser
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Oxantel

Countries in Clinic: Tanzania

Active Clinical Trial Count: 2

Highest Development Phases

Phase 2: Ancylostomiasis|Communicable Diseases|Hookworm Infections|Trichuriasis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
HELP-OXA

P1

Not yet recruiting

Trichuriasis

2025-04-01

OXA-TRI

P2

Not yet recruiting

Ancylostomiasis|Hookworm Infections|Communicable Diseases|Trichuriasis

2025-04-01

Recent News Events

Date

Type

Title

12/01/2023

PubMed

 Trichuris muris egg-hatching assay for anthelminthic drug discovery and characterization.

10/31/2023

PubMed

 The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.

05/04/2023

PubMed

 Development of a hookworm egg hatching assay to determine the ovicidal effects of anthelminthics.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions